SIETES :: 92850 citas

Resultados de la búsqueda por FORMA FARMACÉUTICA REFINAR BÚSQUEDA

1.

Sànchez G. Catalunya se erige en huerta europea del gran negocio de la marihuana. El Periódico 2019:3 de junio. [Ref.ID 103128]

2.

Matta MK, Zusterzeel R, Pilli NR, Patel V, Volpe DA, Florian J, Oh L, Bashaw E, Zineh I, Sanabria C, Kemp S, Godfrey A, Adah S, Coelho S, Wang J, Furlong L-A, Ganley C, Michele T, Strauss DG. Effect of sunscreen application under maximal use conditions on plasma concentration of sunscreen active ingredients. A randomized clinical trial. JAMA 2019:6 de mayo. [Ref.ID 103109]

3.

Hider-Mlynarz K, Cavalié P, Maison P. Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe. Br J Clin Pharmacol 2018;84:junio. [Ref.ID 102806]

4.

Lalic S, Gisev N, Bell JS, Korhonen MJ, Ilomäki J. Predictors of persistent prescription opioid analgesic use among people without cancer in Australia . Br J Clin Pharmacol 2018;84:junio. [Ref.ID 102804]

5.

Anónimo. Artemisia annua soft gel capsules: Reports of liver damage. New Zealand. WHO Drug Information 2018;32:20. [Ref.ID 102624]

6.

Montastruc J-L. A propos du Levothyrox® : les réflexions du pharmacologue médical. BIP31.fr 2017;24:60. [Ref.ID 102182]

7.

8.

Anónimo. FDA approves first digital pill. DIA Daily 2017:1. [Ref.ID 102142]

9.

Anónimo. Former Insys CEO arrested and charged with conspiracy, racketeering for marketing and sales of fentanyl. DIA Daily 2017:2. [Ref.ID 102102]

10.

Anónimo. EMA’s PARC recommends modified-release paracetamol be removed from market. DIA Daily 2017:2. [Ref.ID 102044]

11.

Russo EB. Cannabidiol claims and misconceptions. Trends Pharmacol Sci 2017;38:198-201. [Ref.ID 101988]

12.

Becker WC, Fiellin DA. Abuse-deterrent opioid formulations - Putting the potential benefits into perspective. N Engl J Med 2017;376:2103-5. [Ref.ID 101625]

13.

Anónimo. Medicines, excipients and dietary intolerances. Drug Ther Bull 2016;54:93-6. [Ref.ID 100651]

14.

Anónimo. Cannabis and cannabinoids. Med Lett Drugs Ther 2016;58:97-8. [Ref.ID 100510]

15.

Anónimo. FDA approves Differin Gel 0.1% for over-the-counter use to treat acne. U.S. Food and Drug Administration 2016:8 de julio. [Ref.ID 100485]

16.

Anónimo. FDA approves first dronabinol solution for oral use. U.S. Food and Drug Administration 2016:2. [Ref.ID 100472]

17.

Anónimo. FDA approves first buprenorphine implant for treatment of opioid dependence. U.S. Food and Drug Administration 2016:26 de mayo. [Ref.ID 100323]

18.

Anónimo. ‘Sí’ de la EMA a palmitato de paliperidona, de Janssen, en presentación trimestral. Correo Farmacéutico 2016:17. [Ref.ID 100109]

19.

Anónimo. Drugs past their expiration date. JAMA 2016;315:510-1. [Ref.ID 100021]

20.

Voelker R. New pancreatic cancer drug. JAMA 2015;314:2227. [Ref.ID 99728]